COX-2 inhibitors - Is there cause for concern?

Karen Seibert, James Lefkowith, Catherine Tripp, Peter Isakson, Philip Needleman

Research output: Contribution to journalShort surveypeer-review

16 Scopus citations


A new study calls for further investigation into the potential benefits and risks of COX-2 specific inhibitors (pages 698-701).

Original languageEnglish
Pages (from-to)621-622
Number of pages2
JournalNature medicine
Issue number6
StatePublished - Jun 1999


Dive into the research topics of 'COX-2 inhibitors - Is there cause for concern?'. Together they form a unique fingerprint.

Cite this